What is the current Price Target for the Candel Therapeutics Inc stock?

The average Candel Therapeutics Inc target price is $21.00. This is 335.69% higher than the current stock price. The highest price target is 418.67%, the lowest is 211.20%. 4 Analysts have issued a price target Candel Therapeutics Inc 2026 .

How high will the Candel Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Candel Therapeutics Inc stock will rise. The performance of stocks, including the Candel Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Candel Therapeutics Inc stock today?

The performance of Candel Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Candel Therapeutics Inc stock fall?

The decline in Candel Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Candel Therapeutics Inc Forecast, price target & analysts

$4.82

8.19% today

Nasdaq, Apr 04, 10:00 pm CET

ISIN

US1374041093

Symbol

CADL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Services

Industry

Various services

Overview Dividends Analysts Charts News Strategies

Candel Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Candel Therapeutics Inc Classifications & Recommendation:

Buy

100%

Candel Therapeutics Inc Price Target

Target Price	$21.00
Price	$4.82
Potential	335.69% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Candel Therapeutics Inc 2026 . The average Candel Therapeutics Inc target price is $21.00. This is 335.69% register free of charge higher than the current stock price. The highest price target is $25.00 418.67% register free of charge , the lowest is $15.00 211.20% register free of charge .
	A rating was issued by 4 analysts: 4 Analysts recommend Candel Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Candel Therapeutics Inc stock has an average upside potential 2026 of 335.69% register free of charge . Most analysts recommend the Candel Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.74	-0.92
	32.82%	47.13%
P/E		negative

1 Analysts have issued a Candel Therapeutics Inc forecast for earnings per share. The average Candel Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.74	32.82%
2025	$-0.92 47.13% Unlock
2026	$-0.95 3.26% Unlock

Current	-2.99	109.09%
2025	-5.71 90.97% Unlock
2026	-5.53 3.15% Unlock

Candel Therapeutics Inc...

Current Candel Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 14 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Feb 26 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 26 2025
Citigroup	Locked ➜ Locked	Locked	Feb 20 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Feb 19 2025
B of A Securities	Locked ➜ Locked	Locked	Feb 07 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 18 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 14 2025
Locked Canaccord Genuity: Locked ➜ Locked	Feb 26 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 26 2025
Locked Citigroup: Locked ➜ Locked	Feb 20 2025
Locked Canaccord Genuity: Locked ➜ Locked	Feb 19 2025
Locked B of A Securities: Locked ➜ Locked	Feb 07 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 18 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 95.20%

BioNTech SE - ADR 56.84%

Amazon.com 56.18%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now